Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial.
While prednisolone is commonly used to treat recent nerve function impairment (NFI) in leprosy patients, the optimal treatment duration has not yet been established. In this "Treatment of Early Neuropathy in Leprosy" (TENLEP) trial, we evaluated whether a 32-week prednisolone course is mor...
Main Authors: | Inge Wagenaar, Erik Post, Wim Brandsma, Bob Bowers, Khorshed Alam, Vanaja Shetty, Vivek Pai, Sajid Husain, Cita Rosita Sigit Prakoeswa, Linda Astari, Deanna Hagge, Mahesh Shah, Kapil Neupane, Krishna Bahadur Tamang, TENLEP study group, Peter Nicholls, Jan Hendrik Richardus |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-10-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5643133?pdf=render |
Similar Items
-
A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairment.
by: Stephen L Walker, et al.
Published: (2011-01-01) -
Profil Pasien Dermatitis Kontak Alergi Akibat Kosmetik
by: Marissa Astari Rubianti, et al.
Published: (2019-04-01) -
Topical Epigallocatechin Gallate (EGCG) 1% for Chronic Plantar Ulcers in Leprosy
by: Riyana Noor Oktaviyanti, et al.
Published: (2020-07-01) -
Diet-related risk factors for leprosy: a case-control study.
by: Inge Wagenaar, et al.
Published: (2015-05-01) -
Diagnosis and Management of Leprosy
by: Medhi Denisa Alinda, et al.
Published: (2020-07-01)